Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
MK-1167 for Alzheimer's Disease
Recruiting0 awardsPhase 2
Matthews, North Carolina
This trial aims to investigate whether combining MK-1167 with acetylcholinesterase inhibitor therapy can help improve symptoms of Alzheimer's disease dementia, such as memory and mental activity. The study will
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service